Lynn Seely, President and CEO at Lyell Immunopharma, Inc. (LYEL), sold 14,514 shares at $10.54 ($153K) on 2025-08-21, disclosed to the SEC on 2025-08-22.
Open-market sale of $153k LYEL by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.54 | 7,257 | $76K | 50.0% |
| 2 | $10.54 | 7,257 | $76K | 50.0% |
| Total | $10.54 avg | 14,514 | $153K | 100% |
| Filing → |
| LYEL | SELL | 2026-06-15 | $7K | — | Filing → |
| LYEL | SELL | 2026-02-12 | $174K | — | Filing → |
| LYEL | SELL | 2026-02-11 | $10K | — | Filing → |